𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Re-emergence of anti-topoisomerase I antibody with exacerbated development of skin sclerosis in a patient with systemic sclerosis

✍ Scribed by Yasuhito Hamaguchi; Manabu Fujimoto; Minoru Hasegawa; Takashi Matsushita; Kazuhiko Takehara

Book ID
116585505
Publisher
Elsevier Science
Year
2010
Tongue
English
Weight
183 KB
Volume
62
Category
Article
ISSN
1097-6787

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Clinical subsets, skin thickness progres
Clinical subsets, skin thickness progression rate, and serum antibody levels in systemic sclerosis patients with anti–topoisomerase I antibody
✍ Achini Perera; Noreen Fertig; Mary Lucas; Tatiana S. Rodriguez-Reyna; Paul Hu; V 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 129 KB 👁 2 views

## Abstract ## Objective To describe the clinical and laboratory features and natural history of the disease in systemic sclerosis (SSc; scleroderma) patients with anti–topoisomerase I (anti–topo I) antibody who have different skin thickness progression rates (STPRs). ## Methods SSc patients (n

Association of the PTPN22 R620W polymorp
Association of the PTPN22 R620W polymorphism with anti–topoisomerase I– and anticentromere antibody–positive systemic sclerosis
✍ Pravitt Gourh; Filemon K. Tan; Shervin Assassi; Chul W. Ahn; Terry A. McNearney; 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 88 KB 👁 2 views

## Abstract ## Objective To determine any associations of the __PTPN22__ R620W single‐nucleotide polymorphism (SNP) with systemic sclerosis (SSc) or with anticentromere antibody (ACA)–positive or anti–topoisomerase I (anti–topo I) antibody–positive SSc, in a case–control study of US white, black,